CardioGen-82 PET Scan & Cardiac Positron Emission Tomography (PET) Scan Safety Alert Issued By FDA Over Potential For Increased Radiation Exposure.
A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: CardioGen-82 PET Scan: Drug Safety Communication – Increased Radiation Exposure. According to the Food & Drug Administration FDA’s MedWatch:
FDA notified the public and the medical imaging community about the potential for inadvertent, increased radiation exposure in patients who underwent or will be undergoing cardiac positron emission tomography (PET) scans with rubidium (Rb)-82 chloride injection from CardioGen-82 manufactured by Bracco Diagnostics, Inc.
For more information on the CardioGen-82 PET Scan Radiation safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: CardioGen-82 PET Scan: Drug Safety Communication – Increased Radiation Exposure.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the CardioGen-82 PET Scan Radiation safety alert, share your drug or medical device recall or safety alert comments below.